While CVS Health Corp has underperformed by -0.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CVS fell by -23.52%, with highs and lows ranging from $80.75 to $43.56, whereas the simple moving average fell by -1.74% in the last 200 days.
On January 30, 2025, Edward Jones Upgraded CVS Health Corp (NYSE: CVS) to Buy. A report published by Deutsche Bank on December 03, 2024, Upgraded its rating to ‘Buy’ for CVS. Wells Fargo also Upgraded CVS shares as ‘Overweight’, setting a target price of $66 on the company’s shares in a report dated November 18, 2024. Barclays October 10, 2024d the rating to Overweight on October 10, 2024, and set its price target from $63 to $82. TD Cowen October 04, 2024d its ‘Hold’ rating to ‘Buy’ for CVS, as published in its report on October 04, 2024. Robert W. Baird’s report from May 30, 2024 suggests a price prediction of $61 for CVS shares, giving the stock a ‘Neutral’ rating. TD Cowen also rated the stock as ‘Hold’.
Analysis of CVS Health Corp (CVS)
Investors in CVS Health Corp will get a return regardless of how the company performs over the next quarter since the company’s dividend stands at $2.66 per share. Further, the quarter-over-quarter increase in sales is 6.12%, showing a positive trend in the upcoming months.
One of the most important indicators of CVS Health Corp’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 6.72% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.59, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CVS is recording 13.84M average volume. On a monthly basis, the volatility of the stock is set at 3.06%, whereas on a weekly basis, it is put at 2.99%, with a gain of 3.54% over the past seven days. Furthermore, long-term investors anticipate a median target price of $63.77, showing growth from the present price of $56.48, which can serve as yet another indication of whether CVS is worth investing in or should be passed over.
How Do You Analyze CVS Health Corp Shares?
The Healthcare Plans market is dominated by CVS Health Corp (CVS) based in the USA. When comparing CVS Health Corp shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 14.35, there is a growth in quarterly earnings of -96.06%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 81.36% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CVS shares are owned by institutional investors to the tune of 81.36% at present.
